Antenatal Myo-inositol Supplementation in Pre-existing Diabetes
Recruiting
N/A
Interventional Study
Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 21 – 45
- Sex
- Female
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 182 (estimated)
- Sponsor
- National University Hospital, Singapore · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This feasibility pilot study aims to gather data that can guide the design of a larger, more comprehensive trial to establish the effects of myo-inositol supplementation on supporting healthy outcomes in pregnancies complicated by Type 2 Diabetes Mellitus (T2DM). It seeks to assess myo-inositol's potential to support fetal and neonatal health, and optimise maternity outcomes as a complementary app…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
* Pregnant women aged 21 years to 45 years old at the time of recruitment
* Ongoing, viable, singleton intrauterine pregnancy
* Between 12+0 days-16+6 days weeks' gestation at recruitment
* T2DM diagnosed by a documented 75g Oral Glucose Tolerance Test (OGTT) showing a fasting gl…
Contacts